CLDN1 and Alzheimer disease: The ChP-barrier dysfunction in AD mouse models shared phenotypic similarities with aging-related pathology in junctional components (e.g., CLDN1 and ICAM1) [35, 86] and immune mediators (e.g., IFN-γ) [88].